Note 17 - Subsequent Events

ATM Program Increase

On July 24, 2025, the Company filed a prospectus supplement to increase the capacity of its ATM by up to an additional $100 million. While this filing increases the available capacity under the ATM, the Company is under no obligation to issue any share of its common stock pursuant to the program. The expanded facility is intended to enhance the Company’s financial flexibility, providing an efficient mechanism to access capital if, and when, deemed appropriate. Any utilisation of the ATM will be at the discretion of the Company, taking into account prevailing market conditions and strategic priorities.

As previously disclosed, the ATM is conducted pursuant to the Amended and Restated Sales Agreement, by and among the Company and the Sales Agents. Accordingly, pursuant to the prospectus supplement, the amount of shares of the Company’s common stock that the Company may issue under the Amended and Restated Sales Agreement has been increased by up to an aggregate of $100 million of shares of the Company’s common stock. There can be no assurance that the Sales Agents will be able to complete future placements pursuant to the Amended and Restated Sales Agreement, even if instructed to do so. The number of shares of the Company’s common stock that the Company may ultimately sell under the Amended and Restated Sales Agreement will fluctuate based on a number of factors, including the market price of its common stock during the sales period, the limits it may set in any instruction to sell shares of its common stock, and the demand for its common stock during an applicable sales period.